ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
ARS PHARMACEUTICALS INC
5.51
0.0000
盘前:
5.49
-0.0151
-0.27%
08:15 EDT
成交量:
126.79万
成交额:
699.97万
市值:
5.47亿
市盈率:
-2.53
高:
5.60
开:
5.52
低:
5.47
收:
5.51
52周最高:
14.00
52周最低:
4.91
股本:
9,944.73万
流通股本:
4,803.45万
量比:
0.49
换手率:
2.64%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.1757
每股收益(LYR):
-1.7400
净资产收益率:
-210.35%
总资产收益率:
-48.02%
市净率:
43.75
市盈率(LYR):
-3.16
数据加载中...
总览
公司
新闻资讯
公告
新闻稿:ARS Pharmaceuticals宣布首席执行官继任计划
投资观察
·
07/08
美股动态——Bumble、Tempus AI、TD Synnex
路透中文
·
06/26
ARS Pharma股价暴跌,因其过敏性鼻喷雾剂面临医保报销障碍
路透中文
·
06/25
ARS Pharmaceuticals Inc:2026年现金运营总开支(不含销售成本)下调至2.48亿美元
美股速递
·
06/25
ARS Pharmaceuticals Inc重申Neffy基础业务支持2027年实现现金流盈亏平衡
美股速递
·
06/25
德鲁·布里斯携手ARS制药,提升严重过敏患者的生活质量意识
美股速递
·
06/04
市场快讯——美股行情动态-埃克森美孚、英特尔、英伟达
路透中文
·
05/16
市场快讯——美股行情-Cerebras、Papa John's、航空股
路透中文
·
05/15
热门话题-ARS制药公司股价上涨,因其第一季度营收超出预期
路透中文
·
05/15
ARS Pharmaceuticals:预计多数州级医疗补助计划将在2027年初前将Neffy纳入其无限制药品目录
美股速递
·
05/15
ARS制药公司:CVS Caremark提案进入最终审批阶段,预计6月初发布明确更新
美股速递
·
05/15
ARS Pharmaceuticals任命行业资深人士Donn Casale为总裁,强化领导团队实力
美股速递
·
05/13
BUZZ-加拿大批准无针抗过敏喷雾后,ARS 制药公司股价上涨
路透中文
·
04/15
ARS Pharmaceuticals Inc预计夏季前在加拿大提交Neffy 1毫克用于15-30公斤儿童的审批申请
美股速递
·
04/15
Neffy®(肾上腺素鼻喷雾剂)获加拿大批准,成为首个且唯一用于过敏反应(过敏性休克)的无针急救疗法
美股速递
·
04/15
ARS Pharmaceuticals Inc:Northland Capital 首次覆盖给予“跑赢大盘”评级,目标价25美元
美股速递
·
04/09
ARS Pharmaceuticals获FDA批准移除Neffy® 1毫克(肾上腺素鼻喷雾剂)标签年龄限制
美股速递
·
03/27
Ars Pharmaceuticals, Inc.2025财年实现净利润-1.71亿美元,同比减少2237.50%
市场透视
·
03/10
Ars Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.41%
市场透视
·
03/09
ARS Pharmaceuticals公布2025年第四季度及全年财报,并更新Neffy®(肾上腺素鼻喷雾剂)商业化进展
美股速递
·
03/09
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/SPRY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":5.505,"timestamp":1787342400000,"preClose":5.505,"halted":0,"volume":1267921,"hourTrading":{"tag":"盘前","latestPrice":5.4899,"preClose":5.505,"latestTime":"08:15 EDT","volume":212,"amount":1143.783248,"timestamp":1787573735709,"change":-0.0151,"changeRate":-0.002743,"amplitude":0.018837},"delay":0,"changeRate":0,"floatShares":48034500,"shares":99447343,"eps":-2.175701,"marketStatus":"盘前交易","change":0,"latestTime":"08-24 08:32:48 EDT","open":5.52,"high":5.6,"low":5.465,"amount":6999736.657361001,"amplitude":0.024523,"askPrice":5.51,"askSize":1026,"bidPrice":5.13,"bidSize":33,"shortable":3,"etf":0,"ttmEps":-2.175701,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":5.505,"preHourTrading":{"tag":"盘前","latestPrice":5.4899,"preClose":5.505,"latestTime":"08:15 EDT","volume":212,"amount":1143.783248,"timestamp":1787573735709,"change":-0.0151,"changeRate":-0.002743,"amplitude":0.018837},"postHourTrading":{"tag":"盘后","latestPrice":5.5,"preClose":5.505,"latestTime":"19:48 EDT","volume":9271,"amount":50718.41,"timestamp":1787356109806,"change":-0.005,"changeRate":-0.000908,"amplitude":0.009991},"volumeRatio":0.4943949399407299,"impliedVol":1.0043,"impliedVolPercentile":0.46},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":48034500,"roa":"-48.02%","roe":"-210.35%","lyrEps":-1.74,"volumeRatio":0.4943949399407299,"shares":99447343,"dividePrice":0,"high":5.6,"amplitude":0.024523,"preClose":5.505,"low":5.465,"week52Low":4.9102,"pbRate":"43.75","psRate":"4.68","week52High":13.9987,"institutionHeld":0,"latestPrice":5.505,"committee":-0.937677,"eps":-2.175701,"divideRate":0,"volume":1267921,"delay":0,"ttmEps":-2.175701,"open":5.52,"prevYearClose":11.65,"prevWeekClose":5.505,"prevMonthClose":5.13,"prevQuarterClose":8.01,"fiveDayClose":5.65,"twentyDayClose":5.94,"sixtyDayClose":8.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"SPRY","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"盘后","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-15","symbol":"SPRY","fiscalQuarterEnding":"2026/03","expectedEps":-0.53,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.61},{"market":"US","date":"2026-03-09","symbol":"SPRY","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-11-10","symbol":"SPRY","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"SPRY","fiscalQuarterEnding":"2025/06","expectedEps":-0.41,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1775793600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2026-08-21","current":-2.530219,"percent":0.958425,"low":-115.157754,"twenty":-28.534893,"median":-16.6288,"eighty":-7.404552,"high":184.020638,"avg":-15.30504,"sd":44.472873,"marketCap":547457623},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.313866,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":860429873},{"date":"2024-06-07","current":-17.177383,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":853647205},{"date":"2024-06-14","current":-16.884919,"twenty":-27.543213,"median":-15.872834,"eighty":-9.957071,"marketCap":839112916},{"date":"2024-06-21","current":-15.929536,"twenty":-27.026227,"median":-15.872834,"eighty":-9.981995,"marketCap":791634241},{"date":"2024-06-28","current":-16.592455,"twenty":-26.233342,"median":-15.857321,"eighty":-10.038073,"marketCap":824578628},{"date":"2024-07-05","current":-17.742813,"twenty":-26.122559,"median":-15.901185,"eighty":-10.097267,"marketCap":881746829},{"date":"2024-07-12","current":-22.129772,"twenty":-26.004391,"median":-15.977907,"eighty":-10.112844,"marketCap":1099761155},{"date":"2024-07-19","current":-20.550467,"twenty":-25.84191,"median":-16.008119,"eighty":-10.131537,"marketCap":1021275998},{"date":"2024-07-26","current":-21.408361,"twenty":-25.598187,"median":-16.06602,"eighty":-10.234348,"marketCap":1063909910},{"date":"2024-08-02","current":-19.302621,"twenty":-25.251068,"median":-16.155521,"eighty":-10.620668,"marketCap":959263034},{"date":"2024-08-09","current":-23.520911,"twenty":-24.881793,"median":-16.206368,"eighty":-10.941562,"marketCap":1054724705},{"date":"2024-08-16","current":-28.81744,"twenty":-25.84191,"median":-16.286222,"eighty":-11.035026,"marketCap":1292231647},{"date":"2024-08-23","current":-28.017556,"twenty":-27.270827,"median":-16.393243,"eighty":-11.081758,"marketCap":1256363252},{"date":"2024-08-30","current":-28.060793,"twenty":-27.941591,"median":-16.401625,"eighty":-11.197031,"marketCap":1258302084},{"date":"2024-09-06","current":-24.558599,"twenty":-27.79336,"median":-16.442915,"eighty":-11.309188,"marketCap":1101256678},{"date":"2024-09-13","current":-28.752585,"twenty":-27.79336,"median":-16.472628,"eighty":-11.620736,"marketCap":1289323399},{"date":"2024-09-20","current":-31.930502,"twenty":-27.995938,"median":-16.576918,"eighty":-11.620736,"marketCap":1431827564},{"date":"2024-09-27","current":-30.95767,"twenty":-28.060793,"median":-16.631178,"eighty":-11.714201,"marketCap":1388203840},{"date":"2024-10-04","current":-30.67663,"twenty":-28.212122,"median":-16.751589,"eighty":-11.833393,"marketCap":1375601431},{"date":"2024-10-11","current":-31.39004,"twenty":-28.39555,"median":-16.860498,"eighty":-11.83882,"marketCap":1407592162},{"date":"2024-10-18","current":-34.567957,"twenty":-28.752585,"median":-16.884919,"eighty":-11.967761,"marketCap":1550096327},{"date":"2024-10-25","current":-31.930502,"twenty":-28.968769,"median":-17.021402,"eighty":-12.05734,"marketCap":1431827564},{"date":"2024-11-01","current":-32.989808,"twenty":-29.172776,"median":-17.10772,"eighty":-12.236498,"marketCap":1479328953},{"date":"2024-11-08","current":-36.837898,"twenty":-29.53085,"median":-17.177383,"eighty":-12.27233,"marketCap":1651885017},{"date":"2024-11-15","current":-27.728261,"twenty":-29.574087,"median":-17.203935,"eighty":-12.290246,"marketCap":1361568504},{"date":"2024-11-22","current":-27.708469,"twenty":-29.53085,"median":-17.216378,"eighty":-12.329028,"marketCap":1360596650},{"date":"2024-11-29","current":-28.717849,"twenty":-29.510269,"median":-17.294264,"eighty":-12.329028,"marketCap":1410161242},{"date":"2024-12-06","current":-27.748052,"twenty":-29.318167,"median":-17.323614,"eighty":-12.355333,"marketCap":1362540359},{"date":"2024-12-13","current":-23.552198,"twenty":-29.200708,"median":-17.377363,"eighty":-12.390575,"marketCap":1156507152},{"date":"2024-12-20","current":-22.127191,"twenty":-29.174826,"median":-17.429503,"eighty":-12.426406,"marketCap":1086533610},{"date":"2024-12-27","current":-21.355313,"twenty":-29.123341,"median":-17.460097,"eighty":-12.465821,"marketCap":1048631275},{"date":"2025-01-03","current":-22.146983,"twenty":-29.064257,"median":-17.508842,"eighty":-12.501652,"marketCap":1087505465},{"date":"2025-01-10","current":-22.245942,"twenty":-29.025066,"median":-17.556082,"eighty":-12.530317,"marketCap":1092364739},{"date":"2025-01-17","current":-24.878247,"twenty":-29.013807,"median":-17.625827,"eighty":-12.566149,"marketCap":1221621420},{"date":"2025-01-24","current":-27.866803,"twenty":-28.968769,"median":-17.665522,"eighty":-12.594815,"marketCap":1368371488},{"date":"2025-01-31","current":-25.768876,"twenty":-28.968769,"median":-17.692748,"eighty":-12.61273,"marketCap":1265354884},{"date":"2025-02-07","current":-23.591782,"twenty":-28.81744,"median":-17.719962,"eighty":-12.684394,"marketCap":1158450862},{"date":"2025-02-14","current":-23.7897,"twenty":-28.81245,"median":-17.725862,"eighty":-12.70231,"marketCap":1168169409},{"date":"2025-02-21","current":-22.245942,"twenty":-28.80529,"median":-17.742813,"eighty":-12.730975,"marketCap":1092364739},{"date":"2025-02-28","current":-20.741768,"twenty":-28.766646,"median":-17.750677,"eighty":-12.878556,"marketCap":1018503778},{"date":"2025-03-07","current":-21.474063,"twenty":-28.753554,"median":-17.783612,"eighty":-12.988431,"marketCap":1054462403},{"date":"2025-03-14","current":-23.492823,"twenty":-28.724796,"median":-17.918291,"eighty":-13.032048,"marketCap":1153591588},{"date":"2025-03-21","current":151.633005,"twenty":-28.645299,"median":-17.929848,"eighty":-12.988431,"marketCap":1212760777},{"date":"2025-03-28","current":153.227851,"twenty":-28.604711,"median":-17.78435,"eighty":-12.670061,"marketCap":1225516351},{"date":"2025-04-04","current":157.030944,"twenty":-28.551598,"median":-17.756493,"eighty":-12.515985,"marketCap":1255933491},{"date":"2025-04-11","current":172.365997,"twenty":-28.537065,"median":-17.742813,"eighty":-12.355333,"marketCap":1378583246},{"date":"2025-04-17","current":182.548472,"twenty":-28.53527,"median":-17.728408,"eighty":-12.28308,"marketCap":1460022683},{"date":"2025-04-25","current":168.930945,"twenty":-28.478265,"median":-17.719962,"eighty":-11.916185,"marketCap":1351109701},{"date":"2025-05-02","current":177.55989,"twenty":-28.413636,"median":-17.701176,"eighty":-11.620736,"marketCap":1420124003},{"date":"2025-05-09","current":165.034919,"twenty":-28.363303,"median":-17.672598,"eighty":-11.047488,"marketCap":1319949281},{"date":"2025-05-16","current":-85.348526,"twenty":-28.478265,"median":-17.679674,"eighty":-10.985179,"marketCap":1335704429},{"date":"2025-05-23","current":-91.122103,"twenty":-28.610323,"median":-17.701176,"eighty":-11.047488,"marketCap":1426060905},{"date":"2025-05-30","current":-97.209461,"twenty":-28.755493,"median":-17.719962,"eighty":-11.103567,"marketCap":1521328059},{"date":"2025-06-06","current":-84.344425,"twenty":-28.908237,"median":-17.728408,"eighty":-11.22507,"marketCap":1319990259},{"date":"2025-06-13","current":-90.369027,"twenty":-29.139819,"median":-17.742813,"eighty":-11.433807,"marketCap":1414275278},{"date":"2025-06-20","current":-99.845224,"twenty":-29.414401,"median":-17.756493,"eighty":-11.620736,"marketCap":1562577755},{"date":"2025-06-27","current":-113.463334,"twenty":-29.625971,"median":-17.78435,"eighty":-11.639429,"marketCap":1775701182},{"date":"2025-07-03","current":-103.673356,"twenty":-29.970507,"median":-17.918291,"eighty":-11.714201,"marketCap":1622488027},{"date":"2025-07-11","current":-112.835772,"twenty":-30.109473,"median":-17.96922,"eighty":-11.833393,"marketCap":1765879826},{"date":"2025-07-18","current":-115.157754,"twenty":-30.373971,"median":-18.060207,"eighty":-11.83882,"marketCap":1802218844},{"date":"2025-07-25","current":-112.459234,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"marketCap":1759987013},{"date":"2025-08-01","current":-110.953084,"twenty":-30.649879,"median":-18.318793,"eighty":-12.05734,"marketCap":1736415758},{"date":"2025-08-08","current":-110.764815,"twenty":-30.849578,"median":-18.491503,"eighty":-12.236498,"marketCap":1733469351},{"date":"2025-08-15","current":-29.781475,"twenty":-31.056082,"median":-18.779127,"eighty":-12.27233,"marketCap":1430017096},{"date":"2025-09-05","current":-22.001657,"twenty":-31.011769,"median":-19.029654,"eighty":-12.286663,"marketCap":1056453542},{"date":"2025-09-12","current":-20.890254,"twenty":-30.966274,"median":-19.71207,"eighty":-12.321272,"marketCap":1003087320},{"date":"2025-09-19","current":-20.43746,"twenty":-30.871196,"median":-20.12152,"eighty":-12.329028,"marketCap":981345526},{"date":"2025-09-26","current":-19.63478,"twenty":-30.797693,"median":-20.134768,"eighty":-12.355333,"marketCap":942803254},{"date":"2025-10-03","current":-21.157814,"twenty":-30.698248,"median":-20.149319,"eighty":-12.390575,"marketCap":1015934744},{"date":"2025-10-10","current":-23.833413,"twenty":-30.67,"median":-20.178749,"eighty":-12.426406,"marketCap":1144408982},{"date":"2025-10-17","current":-20.807928,"twenty":-30.653572,"median":-20.2775,"eighty":-12.47657,"marketCap":999134267},{"date":"2025-10-24","current":-19.861177,"twenty":-30.649879,"median":-20.299599,"eighty":-12.515985,"marketCap":953674152},{"date":"2025-10-31","current":-17.74128,"twenty":-30.620337,"median":-20.187599,"eighty":-12.551817,"marketCap":851883024},{"date":"2025-11-07","current":-16.866565,"twenty":-30.612951,"median":-20.149319,"eighty":-12.587649,"marketCap":809881831},{"date":"2025-11-14","current":-10.386267,"twenty":-30.612951,"median":-20.12152,"eighty":-12.426406,"marketCap":831316818},{"date":"2025-11-21","current":-8.311484,"twenty":-30.553867,"median":-19.933213,"eighty":-12.321272,"marketCap":665251152},{"date":"2025-11-28","current":-11.781806,"twenty":-30.491905,"median":-19.75827,"eighty":-12.164835,"marketCap":943015748},{"date":"2025-12-05","current":-12.312852,"twenty":-30.408561,"median":-19.63478,"eighty":-11.836649,"marketCap":985520651},{"date":"2025-12-12","current":-13.856589,"twenty":-30.373971,"median":-19.314339,"eighty":-11.916185,"marketCap":1109081415},{"date":"2025-12-19","current":-12.127603,"twenty":-30.309116,"median":-19.029654,"eighty":-12.021508,"marketCap":970693360},{"date":"2025-12-26","current":-14.177687,"twenty":-30.256997,"median":-18.779127,"eighty":-12.085445,"marketCap":1134782054},{"date":"2026-01-02","current":-14.387635,"twenty":-30.230821,"median":-18.672648,"eighty":-12.149382,"marketCap":1151586318},{"date":"2026-01-09","current":-13.523142,"twenty":-30.165419,"median":-18.491503,"eighty":-12.241889,"marketCap":1082392290},{"date":"2026-01-16","current":-13.696041,"twenty":-30.101841,"median":-18.441052,"eighty":-12.263452,"marketCap":1096231095},{"date":"2026-01-23","current":-13.053846,"twenty":-30.071312,"median":-18.318793,"eighty":-12.263452,"marketCap":1044829818},{"date":"2026-01-30","current":-12.621599,"twenty":-30.016829,"median":-18.156476,"eighty":-12.27233,"marketCap":1010232804},{"date":"2026-02-06","current":-11.942355,"twenty":-30.006457,"median":-18.060207,"eighty":-12.27233,"marketCap":955866068},{"date":"2026-02-13","current":-10.880263,"twenty":-29.970507,"median":-17.96922,"eighty":-12.251102,"marketCap":870856262},{"date":"2026-02-20","current":-11.658307,"twenty":-29.864079,"median":-17.933958,"eighty":-12.08391,"marketCap":933130887},{"date":"2026-02-27","current":-11.534808,"twenty":-29.792674,"median":-17.810106,"eighty":-11.837735,"marketCap":923246026},{"date":"2026-03-06","current":-11.26311,"twenty":-29.719333,"median":-17.772592,"eighty":-11.771926,"marketCap":901499332},{"date":"2026-03-13","current":-4.776529,"twenty":-29.651913,"median":-17.742813,"eighty":-11.650793,"marketCap":818209809},{"date":"2026-03-20","current":-4.782325,"twenty":-29.587058,"median":-17.742047,"eighty":-11.574328,"marketCap":819202782},{"date":"2026-03-27","current":-4.962025,"twenty":-29.539497,"median":-17.728408,"eighty":-11.403899,"marketCap":849984947},{"date":"2026-04-02","current":-4.701171,"twenty":-29.515414,"median":-17.719962,"eighty":-11.300637,"marketCap":805301159},{"date":"2026-04-10","current":-4.793919,"twenty":-29.472136,"median":-17.701176,"eighty":-11.16712,"marketCap":821188728},{"date":"2026-04-17","current":-4.741748,"twenty":-29.342914,"median":-17.679674,"eighty":-11.054765,"marketCap":812251971},{"date":"2026-04-24","current":-4.811309,"twenty":-29.218388,"median":-17.626125,"eighty":-10.944483,"marketCap":824167648},{"date":"2026-05-01","current":-4.788122,"twenty":-29.176877,"median":-17.592246,"eighty":-10.860503,"marketCap":820195755},{"date":"2026-05-08","current":-5.217082,"twenty":-29.123341,"median":-17.508842,"eighty":-10.149584,"marketCap":893675763},{"date":"2026-05-15","current":-4.602781,"twenty":-29.051193,"median":-17.430851,"eighty":-10.056766,"marketCap":788447224},{"date":"2026-05-22","current":-4.128106,"twenty":-29.025066,"median":-17.419754,"eighty":-9.920468,"marketCap":817265846},{"date":"2026-05-29","current":-4.714969,"twenty":-29.002547,"median":-17.374861,"eighty":-9.799739,"marketCap":933450662},{"date":"2026-06-05","current":-4.549443,"twenty":-28.908237,"median":-17.313866,"eighty":-9.477287,"marketCap":900680586},{"date":"2026-06-12","current":-4.810271,"twenty":-28.815444,"median":-17.262136,"eighty":-9.284127,"marketCap":952318282},{"date":"2026-06-18","current":-4.965765,"twenty":-28.81066,"median":-17.21396,"eighty":-9.20624,"marketCap":983102293},{"date":"2026-06-26","current":-4.022771,"twenty":-28.794286,"median":-17.19688,"eighty":-8.798113,"marketCap":796412161},{"date":"2026-07-02","current":-3.982644,"twenty":-28.757432,"median":-17.177383,"eighty":-8.749905,"marketCap":788467900},{"date":"2026-07-10","current":-3.952548,"twenty":-28.752585,"median":-17.10772,"eighty":-8.311484,"marketCap":782509704},{"date":"2026-07-17","current":-3.741879,"twenty":-28.717849,"median":-17.021402,"eighty":-8.1314,"marketCap":740802334},{"date":"2026-07-24","current":-3.009555,"twenty":-28.627161,"median":-16.884919,"eighty":-8.115823,"marketCap":595819572},{"date":"2026-07-31","current":-2.823965,"twenty":-28.604711,"median":-16.872443,"eighty":-8.050398,"marketCap":559077365},{"date":"2026-08-07","current":-2.783838,"twenty":-28.551598,"median":-16.842675,"eighty":-7.822968,"marketCap":551133104},{"date":"2026-08-14","current":-3.064153,"twenty":-28.537065,"median":-16.689461,"eighty":-7.495842,"marketCap":606628792},{"date":"2026-08-21","current":-2.541208,"twenty":-28.534893,"median":-16.6288,"eighty":-7.404552,"marketCap":547457623}],"updateTime":1787537053971},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1121444252","title":"新闻稿:ARS Pharmaceuticals宣布首席执行官继任计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1121444252","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121444252?lang=zh_cn&edition=fundamental","pubTime":"2026-07-08 04:31","pubTimestamp":1783456303,"startTime":"0","endTime":"0","summary":"致力于赋能高危患者及其护理人员、以更好地预防可能导致过敏性休克的过敏反应的生物制药公司ARS Pharmaceuticals, Inc.今日宣布首席执行官继任计划。联合创始人兼首席执行官理查德·洛温塔尔自2026年7月6日起,将不再担任公司雇员及高管职务。董事会已任命现任总裁唐恩·卡萨莱为首席执行官兼董事,自2026年7月7日起生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","SPRY","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646780060","title":"美股动态——Bumble、Tempus AI、TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646780060","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646780060?lang=zh_cn&edition=fundamental","pubTime":"2026-06-26 01:56","pubTimestamp":1782410212,"startTime":"0","endTime":"0","summary":".N美国东部时间13:31,道琼斯工业平均指数.DJI上涨0.31%,报52,008.43点。标普500指数.SPX上涨0.02%,报7,359.41点;纳斯达克综合指数.IXIC下跌0.43%,报25,365.84点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X1V3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV","NNOX","IBM","BX","CRWV","PLTA","CDNL","DRI","PLTD","WEN","AKAM","DELL","BMBL","VANI","QCOM","KYMR","AAPY","PLTR","TSHA","WDC","DPC","MU","CSIQ","MEI","PSTV","SPRY","ILLR","TEM","MOGU","DLTR","HTZ","INMB","MRK","GRAL","SNDK","AYI","STX","NUVB","PRFX","PSNY","LLY","AZI","MKC","CRWG","SNX","TECH","PLTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646805257","title":"ARS Pharma股价暴跌,因其过敏性鼻喷雾剂面临医保报销障碍","url":"https://stock-news.laohu8.com/highlight/detail?id=2646805257","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646805257?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 21:40","pubTimestamp":1782394840,"startTime":"0","endTime":"0","summary":"BUZZ-ARS Pharma股价暴跌,因其过敏性鼻喷雾剂面临医保报销障碍6月25日-** ARS Pharmaceuticals(SPRY.O)股价下跌26%至7.79美元,结束了连续三天的上涨势头** ARS制药公司周三晚间 (link) 表示,其过敏喷雾剂“Neffy”在7月的最新审批周期中未获得任何新的保险报销批准** “Neffy”是一种用于紧急治疗严重过敏反应的肾上腺素鼻喷雾剂,目前已","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4T42X1E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","IE00BSNM7G36.USD","LU0070302665.USD","LU2125909247.SGD","BK4585","IE0002270589.USD","SPRY","CVS","LU2433249047.HKD","LU0061475181.USD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0006061336.USD","LU0072461881.USD","LU0432979614.USD","LU0208291251.USD","BK4196","IE00BKVL7J92.USD","LU1059921491.USD","BK4504","LU2125909593.SGD","LU0211331839.USD","IE00B19Z3B42.SGD","BK4588","LU0162691827.USD","LU1571399168.USD","BK4581","IE00BZ1G4Q59.USD","BK4139","BK4550","LU0320765489.SGD","LU1983299246.USD","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190087573","title":"ARS Pharmaceuticals Inc:2026年现金运营总开支(不含销售成本)下调至2.48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190087573","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190087573?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 04:16","pubTimestamp":1782332174,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc 已将其2026年现金运营总开支(不含销货成本)的预期下调至2.48亿美元。这一调整反映了公司对运营效率的持续优化与成本控制措施的强化。通过审慎的财务规划,公司旨在更有效地配置资源,为未来的研发投入和业务拓展创造更有利的财务空间。此举有望提升公司的整体财务健康度与市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116281092","title":"ARS Pharmaceuticals Inc重申Neffy基础业务支持2027年实现现金流盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=1116281092","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116281092?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 04:15","pubTimestamp":1782332113,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc重申,其核心产品Neffy的基础业务,为公司规划了一条在2027年实现现金流盈亏平衡的可行路径。这一表态强化了公司对未来财务表现的信心与具体预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143413101","title":"德鲁·布里斯携手ARS制药,提升严重过敏患者的生活质量意识","url":"https://stock-news.laohu8.com/highlight/detail?id=1143413101","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143413101?lang=zh_cn&edition=fundamental","pubTime":"2026-06-04 20:04","pubTimestamp":1780574686,"startTime":"0","endTime":"0","summary":"前NFL传奇四分卫德鲁·布里斯宣布与生物制药公司ARS Pharmaceuticals合作,共同发起一项旨在提高公众对严重过敏反应认知的倡议。该合作计划将聚焦于那些与严重过敏共存的个体,致力于推广相关的疾病教育,并探讨创新治疗方案如何改善患者的日常生活。布里斯以其卓越的体育生涯闻名,此次跨界合作凸显了他对公共卫生领域的关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635504039","title":"市场快讯——美股行情动态-埃克森美孚、英特尔、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2635504039","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635504039?lang=zh_cn&edition=fundamental","pubTime":"2026-05-16 00:37","pubTimestamp":1778863058,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30,道琼斯工业平均指数 .DJI 下跌0.87%,报49,626.37点。标普500指数 .SPX 下跌0.89%,报7,434.39点;纳斯达克综合指数 .IXIC 下跌1.15%,报26,328.89点。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4T41S1HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","GLOB","ALK","CDE","MSFY","DXCM","NEMG","SPRY","UAL","ELPW","YSS","SSTK","GEMI","LUV","AMD","AU","INTC","NVDA","ORRF","F","AMAT","AMYY","DAL","ARM","CVX","CCNE","UNTY","GETY","NOW","PSX","VLO","WOK","BW","PZZA","XOM","CBRS","LNZA","FIG","EBC","MSFT","HCWB","HUBC","NEM","FIGG","HL","RXO","FDS","PIII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081300","title":"市场快讯——美股行情-Cerebras、Papa John's、航空股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081300","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081300?lang=zh_cn&edition=fundamental","pubTime":"2026-05-15 19:52","pubTimestamp":1778845964,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4T41S13P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0266512473.USD","LU0354030438.USD","BK4017","LU0055631609.USD","AU","LUV","LU0640476718.USD","BK4077","LU0498741890.SGD","GEMG","LU0724618789.USD","LU2462611646.USD","LU1323610961.USD","BK4082","LU1102505762.USD","LU1223082196.USD","FIG","IE00BMPRXN33.USD","LU1102505929.USD","IE00B19Z3581.USD","LU2065731478.USD","FIGG","LU0345781412.USD","LU0788109121.HKD","LU2498475776.HKD","LU0612318971.USD","LU1923622614.USD","BK4533","IE00B19Z3B42.SGD","BK4548","LU1430597077.USD","BK4534","ALK","BK4209","LU0300736492.USD","LU0266013472.USD","NEMG","LU0654597011.USD","LU0353189763.USD","LU1267930227.SGD","BK4023","BK4500","BK4551","LU2211815571.USD","LU0303821028.USD","LU1023059493.AUD","IE00BFMHRM44.USD","ORRF","BK4585","LU0345780950.USD","PZZA","BK4522","LU0170899867.USD","BK4570","LU2087625088.SGD","BK4532","LU0612318385.USD","IE00BMPRXR70.SGD","NEM","BK4139","LU0143863784.USD","LU2125909247.SGD","UAL","LU0075056555.USD","LU2210149790.SGD","LU2125909593.SGD","BK4008","LU0128525689.USD","LU1223082519.USD","DXCM","LU0303823156.USD","LU0498741114.HKD","LU0496367417.USD","LU0345780521.USD","LU0143863198.USD","BK4504","LU0456854461.SGD","LU0300736062.USD","LU0353189680.USD","LU1223083913.SGD","LU1868837565.USD","LU0278409577.USD","BK4211","LU0266512127.USD","LU1883866441.USD","BK4122","LU0345780281.USD","SSTK","SPRY","LU2095319765.USD","LU2210150020.SGD","GEMI","NWMX","LU0368265764.SGD","CBRS","IE0002270589.USD","LU0310800965.SGD","LU0630314457.HKD","LU2433249047.HKD","SG9999001143.SGD","GETY","LU0052756011.USD","LU0788108826.HKD","LU0354030511.USD","LU1280957306.USD","LU0330918003.SGD","LU1868838027.USD","DAL","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635208599","title":"热门话题-ARS制药公司股价上涨,因其第一季度营收超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2635208599","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635208599?lang=zh_cn&edition=fundamental","pubTime":"2026-05-15 18:48","pubTimestamp":1778842091,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4T41S0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187836714","title":"ARS Pharmaceuticals:预计多数州级医疗补助计划将在2027年初前将Neffy纳入其无限制药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=1187836714","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187836714?lang=zh_cn&edition=fundamental","pubTime":"2026-05-15 18:06","pubTimestamp":1778839603,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals 预计,到2027年初,大多数州级医疗补助计划将把其药物Neffy纳入其无限制的医疗补助药品目录中。这一进展有望扩大该药物的覆盖范围和患者可及性,对公司未来市场拓展具有积极意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165973837","title":"ARS制药公司:CVS Caremark提案进入最终审批阶段,预计6月初发布明确更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1165973837","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165973837?lang=zh_cn&edition=fundamental","pubTime":"2026-05-15 18:04","pubTimestamp":1778839479,"startTime":"0","endTime":"0","summary":"ARS制药公司宣布,其与CVS Caremark的提案已进入审批流程的最后阶段。公司预计将在6月初提供一份明确的更新信息,以披露该提案的最终结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129690559","title":"ARS Pharmaceuticals任命行业资深人士Donn Casale为总裁,强化领导团队实力","url":"https://stock-news.laohu8.com/highlight/detail?id=1129690559","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129690559?lang=zh_cn&edition=fundamental","pubTime":"2026-05-13 20:03","pubTimestamp":1778673829,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals宣布任命行业资深人士唐·卡萨莱(Donn Casale)为公司总裁,此举旨在进一步强化其领导团队。\n卡萨莱在生物制药领域拥有丰富的管理经验,他的加入将为公司带来宝贵的行业洞见和战略领导力。此次人事任命体现了ARS Pharmaceuticals持续加强其管理层,以推动公司未来发展的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627283324","title":"BUZZ-加拿大批准无针抗过敏喷雾后,ARS 制药公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2627283324","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627283324?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 18:16","pubTimestamp":1776248189,"startTime":"0","endTime":"0","summary":"BUZZ-加拿大批准无针抗过敏喷雾后,ARS 制药公司股价上涨4月15日 - ** ARS制药公司SPRY.O股价盘前上涨2%至8.30美元** 药物开发商称加拿大卫生部批准了neffy,一种用于成人和体重超过30公斤的儿童严重过敏反应的无针肾上腺素鼻喷雾剂。** 公司称,neffy 是传统肾上腺素自动注射器的替代品,一些患者因害怕针头而避免使用这种注射器。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL4S40Y0SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158905047","title":"ARS Pharmaceuticals Inc预计夏季前在加拿大提交Neffy 1毫克用于15-30公斤儿童的审批申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1158905047","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158905047?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 18:09","pubTimestamp":1776247779,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc计划于夏季前向加拿大监管机构提交其Neffy 1毫克产品的审批申请,该产品适用于体重在15至30公斤之间的儿童群体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159278174","title":"Neffy®(肾上腺素鼻喷雾剂)获加拿大批准,成为首个且唯一用于过敏反应(过敏性休克)的无针急救疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1159278174","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159278174?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 18:08","pubTimestamp":1776247693,"startTime":"0","endTime":"0","summary":"Neffy®(肾上腺素鼻喷雾剂)已在加拿大获得批准,成为该国首个且唯一用于治疗过敏反应(包括危及生命的过敏性休克)的无针急救疗法。这一批准标志着严重过敏反应应急管理领域的重大突破,为患者提供了一种无需注射的便捷替代方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161492576","title":"ARS Pharmaceuticals Inc:Northland Capital 首次覆盖给予“跑赢大盘”评级,目标价25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161492576","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161492576?lang=zh_cn&edition=fundamental","pubTime":"2026-04-09 19:47","pubTimestamp":1775735233,"startTime":"0","endTime":"0","summary":"Northland Capital 近日宣布对 ARS Pharmaceuticals Inc 启动研究覆盖,并给予“跑赢大盘”的积极评级。该机构同时设定了25美元的目标股价,显示出对公司未来增长潜力的坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189355008","title":"ARS Pharmaceuticals获FDA批准移除Neffy® 1毫克(肾上腺素鼻喷雾剂)标签年龄限制","url":"https://stock-news.laohu8.com/highlight/detail?id=1189355008","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189355008?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 20:05","pubTimestamp":1774613127,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals公司宣布,其研发的Neffy 1毫克剂量肾上腺素鼻喷雾剂已获得美国食品药品监督管理局批准,将取消药品标签中的年龄使用限制。这一重要监管突破意味着该鼻喷雾剂未来可适用于更广泛的年龄群体,为不同年龄段患者提供更便捷的严重过敏反应应急治疗方案。移除年龄限制不仅拓宽了Neffy的适用人群,更凸显了ARS Pharmaceuticals在创新给药系统研发领域的技术实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618603224","title":"Ars Pharmaceuticals, Inc.2025财年实现净利润-1.71亿美元,同比减少2237.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618603224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618603224?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 06:00","pubTimestamp":1773093635,"startTime":"0","endTime":"0","summary":"3月10日,Ars Pharmaceuticals, Inc.公布财报,公告显示公司2025财年净利润为-1.71亿美元,同比减少2237.50%;其中营业收入为84.28百万美元,同比减少5.46%,每股基本收益为-1.74美元。从资产负债表来看,Ars Pharmaceuticals, Inc.总负债2.13亿美元,其中短期债务588000.00美元,资产负债比为1.54,流动比率为0.08。机构评级:截至2026年3月10日,当前有4家机构对Ars Pharmaceuticals, Inc.目标价做出预测,其中目标均价为27.50美元,其中最低目标价为12.00美元,最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310060045a45c9176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310060045a45c9176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618603202","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618603202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618603202?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 22:06","pubTimestamp":1773065186,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时06分,Ars Pharmaceuticals, Inc.股票出现异动,股价急速下跌5.41%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Xenon制药、Relmada Therapeutics, Inc.、Atara Biotherapeutics, Inc.涨幅较大,Relmada Therapeutics, Inc.、Moolec Science Sa、Atara Biotherapeutics, Inc.较为活跃,换手率分别为35.41%、19.04%、18.11%,振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Biohaven Ltd.、An2 Therapeutics, Inc.,振幅分别为33.71%、28.63%、27.37%。Ars Pharmaceuticals, Inc.公司简介:ARS Pharmaceuticals Inc是一家生物制药公司,专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922062695461e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922062695461e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196337167","title":"ARS Pharmaceuticals公布2025年第四季度及全年财报,并更新Neffy®(肾上腺素鼻喷雾剂)商业化进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1196337167","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196337167?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 18:05","pubTimestamp":1773050705,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc(纳斯达克代码:SPRY)近日披露了2025年第四季度及全年的财务业绩,同时就旗下创新产品Neffy®(肾上腺素鼻喷雾剂)的商业化进程提供了最新动态。报告显示,公司在关键财务指标上达成预期目标,并为鼻喷雾剂的上市筹备工作制定了明确时间表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}